GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES
- 1 January 1988
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 28 (1) , 109-143
- https://doi.org/10.1111/j.1365-2265.1988.tb01209.x
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- THE EFFECT OF OXANDROLONE ON THE GROWTH HORMONE RESPONSE TO GROWTH HORMONE RELEASING HORMONE IN CHILDREN WITH CONSTITUTIONAL GROWTH DELAYClinical Endocrinology, 1986
- GROWTH HORMONE RESPONSES TO GRF 1–29 IN PATIENTS WITH PRIMARY HYPOTHYROIDISM BEFORE AND DURING REPLACEMENT THERAPY WITH THYROXINEClinical Endocrinology, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Somatostatin antagonist analogue stimulates growth in ratsLife Sciences, 1985
- Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1985
- Acromegaly Due to Secretion of Growth Hormone by an Ectopic Pancreatic Islet-Cell TumorNew England Journal of Medicine, 1985
- Acceleration of Growth in Two Children Treated with Human Growth Hormone-Releasing FactorNew England Journal of Medicine, 1985
- Specific binding of synthetic human pancreatic growth hormone releasing factor (1–40-OH) to bovine anterior pituitariesBiochemical and Biophysical Research Communications, 1985
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityNew England Journal of Medicine, 1984
- The effects of long term growth hormone releasing factor (GRF 1–40) administration on growth hormone secretion and synthesis in vitroBiochemical and Biophysical Research Communications, 1984